Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
University of Pittsburgh
St. Jude Children's Research Hospital
Children's Oncology Group
University of Kentucky
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Hoosier Cancer Research Network
Albert Einstein College of Medicine
Novartis
Henry Ford Health System
City of Hope Medical Center
OHSU Knight Cancer Institute
Children's Hospital Los Angeles
Children's Oncology Group
Children's Oncology Group
University of Colorado, Denver
NYU Langone Health
Children's Oncology Group
Roswell Park Cancer Institute
Tufts Medical Center
Children's Oncology Group
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Ohio State University Comprehensive Cancer Center
MedImmune LLC
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Duke University